Poop pills for kids? new study tests fecal transplants against stubborn gut infections
NCT ID NCT02636517
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a fecal transplant (FMT) can safely and effectively treat recurrent C. difficile infections in children, including those with inflammatory bowel disease (IBD). Researchers will give FMT to 250 children aged 3-21 and track whether the infection comes back. The goal is to see if FMT works better than standard antibiotics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. scope: a gentler way to spot pouch inflammation?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can we predict how kids with IBD will respond to treatment?
- Could IBD medications during pregnancy shape a Child's development?
- AI reads scans to forecast Crohn's complications
- Can stem cell vesicles heal Crohn's fistulas?